Suvorexant is an aromatic amide that acts as a dual antagonist of orexin receptors, promoting sleep by reducing wakefulness and arousal. It is used in pharmaceutical manufacturing as an active pharmaceutical ingredient for the management of insomnia.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1030377-33-3
Suvorexant metabolite M9
Suvorexant active metabolite
Nemorexant
orexin receptor antagonist
(1R)-2,3-dihydro-1H-inden-1-amine hydrochloride
active pharmaceutical ingredient
Cidecin
active pharmaceutical ingredient
Tribenoside
active pharmaceutical ingredient
Levamlodipin
active pharmaceutical ingredient
5-chloro-2-[(5S)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole
orexin receptor antagonist pharmaceutical
[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
JYTNQNCOQXFQPK-MRXNPFEDSA-N
C[C@@H]1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl